CLINICAL_TRIALS
trial_result
· 2012-09-14
Clinical Trial Update: Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency [Phase 2]
Summary
Phase 2 clinical trial update on rAAV1-CB-hAAT for alpha-1 antitrypsin deficiency has completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beacon Therapeutics | Conditions: Alpha-1 Antitrypsin Deficiency | Phase 2 | Status: COMPLETED | Results posted: 2012-09-14